Myriad Genetics Inc: Jefferies Financial assumes underwriting rating as poor performance; target stock price is $20 / $25.
Myriad Genetics Inc：杰富瑞假设承保评级为表现不佳；目标股价为20美元兑25美元
Myriad Genetics Inc.: Jefferies assumes an underwriting rating of underperformance; targets $20 to $25
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.